A novel role of metalloproteinase in cancer-mediated immunosuppression

Cancer Research

Volumn 61, Issue 1, 2001, Pages 237-242

  Sheu, Bor Ching ^a   Hsu, Su Ming ^a   Ho, Hong Nerng ^a   Lien, Huang Chun ^a   Huang, Su Cheng ^a   Lin, Rong Hwa ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; INTERLEUKIN 2 RECEPTOR; INTERSTITIAL COLLAGENASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; CANCER IMMUNOLOGY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR ASSOCIATED LEUKOCYTE; UTERINE CERVIX CANCER;

CERVIX UTERI; COCULTURE TECHNIQUES; DOWN-REGULATION; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-2; ISOENZYMES; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; METALLOENDOPEPTIDASES; RECEPTORS, INTERLEUKIN-2; STROMAL CELLS; T-LYMPHOCYTES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSCRIPTION, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 0035137707     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. The host-tumor immune conflict: From immunosuppression to resistance and destruction
2. Escape from host-antitumor immunity
3. Clinical promise of tumor immunology
4. Tumor immunology
5. Immunological ignorance of silent antigens as an explanation of tumor evasion
6. Selective immunosuppressive action of a factor produced by colon cancer cells
7. Lack of IL-2 cytokine expression despite IL-2 messenger RNA transcription in tumour-infiltrating lymphocytes in primary human breast carcinoma: Selective expression of early activation markers
8. Down-regulation of CD25 expression on activated tumour-infiltrating lymphocytes derived from human cervical carcinoma
9. Tumour-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: Role of soluble products from renal cell carcinomas
10. Isolation and characterization of tumor-infiltrating lymphocytes from cervical carcinoma
11. Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma
12. Functional properties of tumour-infiltrating and blood lymphocytes in patients with solid tumour: Effects of tumour cells and their supernatants on proliferative responses of lymphocytes
13. Proliferative and cytolytic potentials of purified human tumor-infiltrating T lymphocytes, impaired response to mitogen-driven stimulation despite T-cell receptor expression
14. Tumour-infiltrating lymphocytes in cervical carcinoma
15. The IL-2/IL-2 receptor system: A target for rational immune intervention
16. The soluble interleukin-2 receptor: Biology, function, and clinical application
17. Metabolism of Tac (IL-2Rα): Physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding
18. Proteolytic cleavage of CD25, the α subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity
19. Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma
20. Characterization of extracellular matrix degrading proteinase and its inhibitors in gynecologic cancer tissues with clinical different metastatic form
21. Matrix metalloproteinase in immunity
22. Neutral metalloproteinases produced by human mononuclear phagocytes
23. T cell gelatinases mediate basement membrane transmigration
24. Processing of tumour necrosis factor-α precursor by metalloproteinases
25. A matrix metalloproteinase expressed on the surface of invasive tumour cells
26. Interaction between tissue inhibitor of metalloproteinase-2 and progelatinase A: Immunoreactivity analyses
27. Production and regulation of gelatinase B by human T-cells
28. Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor
29. A metalloproteinase inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor
30. A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells
31. Matrix metalloproteinase deficiencies affect contact hypersensitivity: Stromelysin-l deficiency prevents the response and gelatinase B deficiency prolongs the response
32. Functional responses and apoptosis of CD25 (IL-2Rα)-deficient T cells expressing a transgenic antigen receptor
33. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis